Literature DB >> 14575524

Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).

Ofer Cohen1, Chanoch Kronman, Baruch Velan, Avigdor Shafferman.   

Abstract

An array of 13 biochemically well defined molecular forms of bovine, human and newly cloned rhesus macaque (Macaca mulatta) AChEs (acetylcholinesterases) differing in glycosylation and subunit assembly status were subjected to comparative pharmacokinetic studies in mice and rhesus macaques. The circulatory lifetimes of recombinant bovine, macaque and human AChEs in mice were governed by previously determined hierarchical rules; the longest circulatory residence time was obtained when AChE was fully sialylated and tetramerized [Kronman, Chitlaru, Elhanany, Velan and Shafferman (2000) J. Biol. Chem. 275, 29488-29502; Chitlaru, Kronman, Velan and Shafferman (2001) Biochem. J. 354, 613-625]. In rhesus macaques, bovine molecular forms still obeyed the same hierarchical rules, whereas primate AChEs showed significant deviation from this behaviour. Residence times of human and rhesus AChEs were effectively extended by extensive sialylation, but subunit tetramerization and N-glycan addition had a marginal effect on their circulatory longevity in macaques. It appears that the major factor responsible for the differential pharmacokinetics of bovine and primate AChEs in macaques is related to differences in primary structure, suggesting the existence of a specific mechanism for the circulatory clearance of primate AChEs in rhesus macaques. The 35 amino acids that differ between bovine and primate AChEs are clustered within three defined domains, all located at the enzyme surface, and may therefore mediate the facilitated removal of primate cholinesterases specifically from the circulation of monkeys. These surface domains can be effectively masked by poly(ethylene glycol) appendage, resulting in the generation of chemically modified human and macaque AChEs that reside in the circulation for extraordinarily long periods of time (mean residence time of 10000 min). This extended residence time is similar to that displayed by native macaque butyrylcholinesterase (9950 min), which is the prevalent cholinesterase form in the circulation of adult macaques.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14575524      PMCID: PMC1223925          DOI: 10.1042/BJ20031305

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  [Use of serum cholinesterases in severe organophosphorus poisoning. Our experience].

Authors:  C Cascio; C Comite; M Ghiara; G Lanza; A Ponchione
Journal:  Minerva Anestesiol       Date:  1988 Jul-Aug       Impact factor: 3.051

2.  Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation.

Authors:  C Kronman; B Velan; D Marcus; A Ordentlich; S Reuveny; A Shafferman
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

3.  N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis.

Authors:  B Velan; C Kronman; A Ordentlich; Y Flashner; M Leitner; S Cohen; A Shafferman
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

4.  A faster-acting and more potent form of tissue plasminogen activator.

Authors:  B A Keyt; N F Paoni; C J Refino; L Berleau; H Nguyen; A Chow; J Lai; L Peña; C Pater; J Ogez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Acetylcholinesterase prophylaxis against organophosphate toxicity.

Authors:  A D Wolfe; R S Rush; B P Doctor; I Koplovitz; D Jones
Journal:  Fundam Appl Toxicol       Date:  1987-08

Review 6.  Noncholinergic functions of cholinesterases.

Authors:  A S Balasubramanian; C D Bhanumathy
Journal:  FASEB J       Date:  1993-11       Impact factor: 5.191

7.  Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid.

Authors:  J C Bigge; T P Patel; J A Bruce; P N Goulding; S M Charles; R B Parekh
Journal:  Anal Biochem       Date:  1995-09-20       Impact factor: 3.365

8.  Evaluation of anchorage-dependent cell propagation systems for production of human acetylcholinesterase by recombinant 293 cells.

Authors:  A Lazar; S Reuveny; C Kronman; B Velan; A Shafferman
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

9.  Oxidative stress-induced activation of microsomal glutathione S-transferase in isolated rat liver.

Authors:  Y Aniya; A Naito
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

10.  Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit.

Authors:  C Kronman; B Velan; Y Gozes; M Leitner; Y Flashner; A Lazar; D Marcus; T Sery; Y Papier; H Grosfeld
Journal:  Gene       Date:  1992-11-16       Impact factor: 3.688

View more
  5 in total

1.  Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agents.

Authors:  Brian C Geyer; Latha Kannan; Pierre-Emmanuel Garnaud; Clarence A Broomfield; C Linn Cadieux; Irene Cherni; Sean M Hodgins; Shane A Kasten; Karli Kelley; Jacquelyn Kilbourne; Zeke P Oliver; Tamara C Otto; Ian Puffenberger; Tony E Reeves; Neil Robbins; Ryan R Woods; Hermona Soreq; David E Lenz; Douglas M Cerasoli; Tsafrir S Mor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

2.  Pharmacokinetics of OpdA, an organophosphorus hydrolase, in the African green monkey.

Authors:  Colin J Jackson; Colin Scott; Angela Carville; Keith Mansfield; David L Ollis; Steven B Bird
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

Review 3.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

4.  Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath.

Authors:  Tama Evron; Brian C Geyer; Irene Cherni; Mrinalini Muralidharan; Jacquelyn Kilbourne; Samuel P Fletcher; Hermona Soreq; Tsafrir S Mor
Journal:  FASEB J       Date:  2007-05-02       Impact factor: 5.191

Review 5.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2009 Mar-Apr       Impact factor: 10.946

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.